AMGNon logo

Amgen Inc (AMGN)

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease;...

NASDAQHealthcareDrug Manufacturers - GeneralUSA

Company Profile

Stock Code
AMGN
ISIN Code
US0311621009
Currency
US Dollar (USD)
IPO Date
1983-06-17

Contact Information

Company Address
One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799
Contact Phone
805 447 1000
Company Website
https://www.amgen.com
Fiscal Year End
December

Financial Highlights

Market Capitalization
$999,999.99
Gross Profit (TTM)
$999,999.99
Dividend Yield
2.92%
Return on Assets (TTM)
8.35%
EBITDA
$999,999.99
Revenue (TTM)
$999,999.99